Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten Luke Timmerman 10/08/09 Boston
Boston-Area Tech Layoffs Slow: A Recap of Summer’s Job Cuts at Analog Devices, CombinatoRx, and Other Firms Ryan McBride 08/17/09 Boston
VMware Springs for SpringSource, Turbine Takes $6.7M, CombinatoRx Teams With Clinical Data, & More Boston-Area Deals News Rebecca Zacks 08/14/09 Boston
$252M Potential in CLDA and CombinatoRx Deal Ryan McBride 08/13/09 Boston
Biogen Idec Buys MS Drug Rights, Immuneering Models Cancer Drug Responses, Hologic Wins Contraceptive Device Approval, & More Boston-Area Life Sciences News Rebecca Zacks 07/08/09 Boston
Former CEO Alexis Borisy Voices Mixed Feelings on CombinatoRx Saga Ryan McBride 07/06/09 Boston
LogMeIn Pulls Off a $107 million IPO, CombinatoRx To Pair With Neuromed, CloudSwitch Turns on $8M, & More Boston-Area Deals News Rebecca Zacks 07/06/09 Boston
CombinatoRx to Combine with Neuromed, CEO Borisy Steps Down Ryan McBride 07/01/09 Boston
Genentech Veteran Takes Agios’ Helm, E8 and MIT Take on Navigenics, Genzyme’s Mipomersen Takes Next Step, Alnylam Takes Advantage of Tekmira Technology, & More Boston-Area Life Sciences News Rebecca Zacks 05/28/09 Boston
CombinatoRx Diabetes Drug Shows Promise Ryan McBride 05/27/09 Boston
Battery Ventures Backs ExactTarget, $22M for Tokai Pharmaceuticals, Ironwood Banks $40M in European Deal, & Much Much More Boston-Area Deals News Rebecca Zacks 05/11/09 Boston
Ironwood Inks $40M Deal with Laboratorios Almirall, CombinatoRx and Novartis Seek Combo Cancer Drugs, NABsys Nabs $4M, & More Boston-Area Life Sciences Deals Rebecca Zacks 05/07/09 Boston
CombinatoRx Cuts Deal for Cancer Drug Discovery with Novartis Ryan McBride 05/06/09 Boston
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter Luke Timmerman 03/17/09 Boston
The Greater Boston Diabetes Cluster Ryan McBride 02/09/09 Boston
Broad Institute Scientists’ Forma Therapeutics Raises $25M, Aims to Knock Out Underpinnings of Cancer Ryan McBride 01/06/09 Boston
Economy Makes Disease Foundations Get Choosier Ryan McBride 12/15/08 Boston
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News Rebecca Zacks 11/26/08 Boston
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter Luke Timmerman 11/25/08 Boston
Reported Job Cuts at NameMedia, WSI Add to Week’s Total Wade Roush 11/21/08 Boston
CombinatoRx Cuts 30 More Jobs, Wiping out Two-Thirds of Staff in Last Month Luke Timmerman 11/20/08 Boston
CombinatoRx Cuts 45 Percent of Staff After Arthritis Drug Failure Luke Timmerman 11/04/08 Boston
No Appeal for Boston Scientific, No Luck for CombinatoRx Drug, No Complaints From Harvard, & More Boston-Area Life Sciences News Rebecca Zacks 10/08/08 Boston
CombinatoRx Reckoning Arrives: Stock Crashes on Failed Arthritis Trial Luke Timmerman 10/06/08 Boston
Link Makes $40M Connection, Concert and Indevus Launch Clinicals, Genzyme’s Big Cholesterol Strategy, & More Boston-Area Life Sciences News Rebecca Zacks 10/01/08 Boston
CombinatoRx Judgment Day Coming Soon, Arthritis Drug Results On the Way Luke Timmerman 09/30/08 Boston
Cortria Hires CEO Grau To Develop Heart Drugs That Won’t Make You Red in the Face Luke Timmerman 07/16/08 Boston
Will CombinatoRx Be the Next Cambridge Biotech Put on the Block? Rebecca Zacks 06/18/08 Boston
Take Two Blueberry Jelly Beans and Call Me in the Morning: Cambridge Biotech’s Best and Brightest on Show (or Not) Erik Mellgren 05/02/08 Boston
In Latest Local Venture Philanthropy Deal, Cystic Fibrosis Foundation Pledges up to $37.7 More to Epix Rebecca Zacks 04/07/08 Boston
Page 1 of 2 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.